Website & contact details
- Group website
- The site of this company’s group or brand.
Abingworth Second Partner Limited
- Incorporated
- 29 March 2012 (14 years)
- Previously known as
- Abingworth Bioventures VI Second Partner Limited (until 28 May 2015)This list may be incomplete. See all names on Companies House
- Industry
- Activities of venture and development capital companies (64303)
- Owned by
- The Carlyle Group Inc.
- Accounts type
- Small
- Region
- Greater London
- Address
- 1 St. James's MarketLondonSW1Y 4AH
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 12 April 2027
- Last conf. stmt
- 29 March 2026
Officers 4 active
Officer details are public data from the Companies House register.
O'Reilly, Emma Jane
Secretary · Appointed 21 July 2025
Director · Appointed 25 March 2025
American
Born July 1975 (51)
Director · Appointed 25 March 2025
British
Born April 1980 (46)
Director · Appointed 25 March 2025
American
Born October 1983 (43)
Officer history (8 former)
1 April 2026
1 April 2026
21 July 2025
Resigned Heard, John as Secretary
21 July 2025
Appointed O'Reilly, Emma Jane as Secretary
21 July 2025
21 July 2025
25 March 2025
25 March 2025
25 March 2025
25 March 2025
16 May 2023
16 May 2023
10 December 2019
16 September 2019
16 September 2019
16 September 2019
7 June 2016
29 March 2012
29 March 2012
29 March 2012
Appointed Heard, John as Secretary
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
The Carlyle Group Inc.
Corporate entity · Notified 1 August 2022
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Corporation
Reg. no. 5011921
Former controllers (1)
1 August 2022
Ceased Abingworth LLP — Owns 75–100% of shares
Group structure 13 shown
Ownership group derived from the Companies House PSC register
Abingworth Second Partner Limited This company
Abingworth CCD 2 General Partner LLP Holds 25–50% of voting rights
Abingworth Clinical Co-Development Fund 2 GP LP Right to appoint and remove a person
Abingworth CCD General Partner LLP Right to 25–50% of surplus assets
Abingworth Clinical Co-Development GP LP Right to appoint and remove a person
Abingworth General Partner 8 LLP Holds 25–50% of voting rights
Abingworth Bioventures 8 GP LP Right to appoint and remove a person
Cytospire Therapeutics Limited Owns 25–50% of shares
Abingworth General Partner VI LLP Right to 25–50% of surplus assets
Abingworth Bioventures VI GP LP Right to appoint and remove a person
Abingworth Avillion Blocker Limited Owns 75–100% of shares
Abingworth General Partner Vii LLP Holds 25–50% of voting rights
Abingworth Bioventures Vii GP LP Right to appoint and remove a person
Filings
Filing history not loaded yet. See it on Companies House
Some other companies at this address
Other companies in this industry
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →